期刊文献+

卡维地洛对原发性高血压患者血管内皮功能的干预作用 被引量:2

A study on carvedilol improving the endothelium function in essential hypertension
原文传递
导出
摘要 目的 探讨卡维地洛对原发性高血压患者血管内皮功能的干预作用。方法 利用高频血管超声技术测量卡维地洛治疗前后原发性高血压患者肱动脉血流及内径的变化 ,根据患者左室几何形态参数 ,将治疗组分为左室肥厚组 (A组 )及无左室肥厚组 (B组 ) ,分析其变化规律。结果 卡维地洛组治疗后内皮依赖性血管舒张功能和内皮非依赖性血管舒张功能均有显著性的改善 (P <0 0 5 ) ,高血压伴左室肥厚组改变更显著 ,与对照组比较差异有显著意义 (P <0 0 5 ) ;血管内皮依赖性的最大血流量较治疗前显著升高 (P <0 0 5 ) ;肱动脉的基础内径与治疗前比较差异无显著意义 (P >0 0 5 )。结论 卡维地洛能改善高血压患者肱动脉内皮依赖性及内皮非依赖性的舒张作用 ,减轻内皮功能的损害。 Objective To investigate the changes of endothelium function in essential hypertension(EH) patients after treatment with carvedilol.Methods All selected EH patients were divided into 2 groups:one(group A) group with left ventricle hypertrophy,the other(group B) group without left ventricle hypertrophy by using 2 diemensional echocardiography;to detect the endothelium dependent and non endothelium dependent vasodilatation change of brachial artery before and after carvedilol.Results After treatment the endothelium dependent and non endothelium dependent vasodiation of brachial artery increased significantly(P<0.05) in carvedilol group.And the change in group A was more significantly(P<0.05).Conclusion Carvedilol can improve the endothelium dependent and non endothelium dependent vasodilatation of brachial artery,lessen the damage of endothelium function in EH.
出处 《中国基层医药》 CAS 2004年第12期1420-1421,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 卡维地洛 原发性高血压 血管内皮功能 干预作用 治疗 Carvedilol Essential hypertension Endothelium function
  • 相关文献

参考文献1

二级参考文献1

共引文献56

同被引文献22

  • 1崔淑兰,李果明,杨健,赵玉兰.伊贝沙坦治疗高血压病的疗效及对血管内皮功能的影响[J].中国基层医药,2004,11(5):527-528. 被引量:3
  • 2冯润川,潘华,许丁空,陈富荣.替米沙坦和福辛普利对高血压左室肥厚患者血浆内皮素和一氧化氮浓度的影响[J].江苏医药,2007,33(4):350-352. 被引量:6
  • 3Pearson TA,Mensah GA,Alexander RW.Markers of inflammation and cardiovascular disease:application to clinical and public health practice:A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American HeartAssociatio.Circulation,2003,107(3):499-511.
  • 4Wallace SM,Yasmin L,McEniery CM,et al.Isolate systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction.Hypertension,2007,50(1):228-233.
  • 5zoghi M,Nalbantgil I.Hypertension and endotheialdysfunction.J Anadolu Kardiyol Derg,2002.2(2):142-147.
  • 6Pagnin E,Giacon V,Zaghetto F,et al.Arterial hypertension and oxidative stress induced by cyclosporine effect of Carvedilol.AnnltalMed int,2001,16(2):101-105.
  • 7Yang SP,Ho LJ,Lin YL,et al.Carvedilol,a new antioxidative beta-blocker,blocks in vitro human peripheral blood T cell activation by downregulating NF-kappa B activity[J].Cardiovasc Res,2003,59(3):776-787.
  • 8Kalinowski L,Dobrucki LW,Szczepanska-Konkel M,et al.Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux:a novel mechanism for antihypertensive action[J].Circulation,2003,107(21):2 747-2 752.
  • 9Kurosaki K,Ikeda U,Maeda Y,et al.Carvedilol stimulates nitric oxide synthesis in rat cardiac myocytes[J].J Mol Cell Cardiol,2000,32(2):333-339.
  • 10Brehm BR,Bertsch D,Von Fallois J,et al.Beta-blockers of the third generation inhibit endothelin-1 liberation, mRNA production and proliferation of human coronary smooth muscle and endothelial cells[J].Cardiovasc Pharmacol,2000,36(Suppl 1):401-403.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部